Paula Virkkula1, Maija Hytönen1, Anni Koskinen2, Sari Hammarén-Malmi1, Jyri Myller3, Marjukka Mäkelä4, Elina Penttilä5, Timo Pessi6, Tuomo Puhakka7, Antti Raappana8,9, Rami Taulu10, Sanna Toppila-Salmi11. 1. Department of Otorhinolaryngology- Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, PO Box 263, 00029, Helsinki, Finland. 2. Department of Otorhinolaryngology- Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, PO Box 263, 00029, Helsinki, Finland. anni.koskinen@hus.fi. 3. Department of Otorhinolaryngology, Päijät-Häme Central Hospital, Lahti, Finland. 4. Section of General Practice, Department of Public Health, Copenhagen University, Copenhagen, Denmark. 5. Department of Otorhinolaryngology, Head and Neck Surgery, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland. 6. Elisa Oyj, Healthcare Solutions, Helsinki, Finland. 7. Department of Otorhinolaryngology, Head and Neck Surgery, Turku University Hospital and University of Turku, Turku, Finland. 8. Department of Otorhinolaryngology and Head and Neck Surgery, Oulu University Hospital, Oulu, Finland. 9. PEDEGO Research Unit, University of Oulu, Oulu, Finland. 10. Department of Otorhinolaryngology, Head and Neck Surgery, Tampere University Hospital and University of Tampere, Tampere, Finland. 11. Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Abstract
PURPOSE: The Sino-Nasal Outcome Test-22 (SNOT-22) is the most commonly used disease-specific quality of life questionnaire in rhinology. The purpose of this prospective study was to translate and validate SNOT-22 into Finnish. METHODS: The validation process followed the guidelines proposed for cross-cultural adaptation of health-related measures of quality of life. The study consisted of three groups: rhinologic out-patients (N = 96), FESS patients (N = 49) and healthy controls (N = 79). Out-patient and FESS groups completed the questionnaire twice (answers A and B), out-patients after two weeks and FESS patients after 3 months. Validity, reliability and responsiveness were evaluated. RESULTS: The mean SNOT-22 sum score of the out-patient questionnaires were 35.3 points (answer A) and 32.4 points (answer B). ICC in out-patient group was 0.879. For the FESS patients, the mean pre- and postoperative (answer A and B) SNOT-22 sum scores were 46.8 and 21.9 points, respectively (p < 0.0001). The mean SNOT-22 of healthy controls was 8.9 points. The out-patients (answer A) and healthy controls had statistically significant difference in SNOT-22 scores (p < 0.0001). CONCLUSIONS: The results of our study show that the validated Finnish version of the SNOT-22 questionnaire demonstrates good validity, reliability and responsiveness.
PURPOSE: The Sino-Nasal Outcome Test-22 (SNOT-22) is the most commonly used disease-specific quality of life questionnaire in rhinology. The purpose of this prospective study was to translate and validate SNOT-22 into Finnish. METHODS: The validation process followed the guidelines proposed for cross-cultural adaptation of health-related measures of quality of life. The study consisted of three groups: rhinologic out-patients (N = 96), FESS patients (N = 49) and healthy controls (N = 79). Out-patient and FESS groups completed the questionnaire twice (answers A and B), out-patients after two weeks and FESS patients after 3 months. Validity, reliability and responsiveness were evaluated. RESULTS: The mean SNOT-22 sum score of the out-patient questionnaires were 35.3 points (answer A) and 32.4 points (answer B). ICC in out-patient group was 0.879. For the FESS patients, the mean pre- and postoperative (answer A and B) SNOT-22 sum scores were 46.8 and 21.9 points, respectively (p < 0.0001). The mean SNOT-22 of healthy controls was 8.9 points. The out-patients (answer A) and healthy controls had statistically significant difference in SNOT-22 scores (p < 0.0001). CONCLUSIONS: The results of our study show that the validated Finnish version of the SNOT-22 questionnaire demonstrates good validity, reliability and responsiveness.
Authors: Gonzalo de los Santos; Pablo Reyes; Raúl del Castillo; Claudio Fragola; Ana Royuela Journal: Eur Arch Otorhinolaryngol Date: 2014-12-16 Impact factor: 2.503
Authors: S E Erskine; C Hopkins; A Clark; S Anari; N Kumar; A Robertson; S Sunkaraneni; J A Wilson; S Carrie; N Kara; J Ray; R Smith; C M Philpott Journal: Clin Otolaryngol Date: 2016-06-09 Impact factor: 2.597
Authors: Francesco Mozzanica; A Preti; R Gera; S Gallo; C Bulgheroni; F Bandi; F Ottaviani; P Castelnuovo Journal: Eur Arch Otorhinolaryngol Date: 2016-09-27 Impact factor: 2.503